Overall rank by patents
#20,474
of 50,000 tracked assignees
USPTO PatentsView assignee record - 14 granted patents across 8 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61H (PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFI).
The verdict
According to USPTO PatentsView, Sunlighten ranks #20,474 of 50,000 tracked US assignees by granted-patent volume, with 14 patents across 8 technology areas.
USPTO PatentsView assignee plate
Corpus R20474 · US Corporation #20,474 · 14 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Stoneridge Control Devices, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Sunlighten · this assignee
42 score
3D Lighting Innovati… · lowest
7 score
What this shows Sunlighten's Innovation Score is 41.7/100 (top 32% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Sunlighten, Llc is a focused PatentsView assignee: 8 CPC subclasses with 85.7% of grants classified under A61H (PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFI). Peak complete grant year is 2024 (3 grants) versus a trough of 1 in 2019. By volume, Sunlighten sits between Stoneridge Control Devices, Inc. and Surface Tech Llc.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Stoneridge Control Devices, Inc.
14 patents
Stratos Genomics, Inc.
14 patents
Strawberry Sciences, LLC
14 patents
Sumita Optical Glass, Inc.
14 patents
SuperTurbo Technologies, Inc.
14 patents
SureHarvest, Inc.
14 patents
Surefire Medical, Inc.
14 patents
Surface Tech LLC
14 patents
Sunlighten, LLC
14 patents
What this shows Sunlighten holds 14 patents at rank #20,472, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #20,472 in granted patent volume.
Other assignees with the most granted patents in Sunlighten's primary technology class.
Sunlighten's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
42 Top 32% higher than 68% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 2 | 14.3% |
| 2019 | 1 | 7.1% |
| 2020 | 2 | 14.3% |
| 2021 | 1 | 7.1% |
| 2022 | 2 | 14.3% |
| 2023 | 2 | 14.3% |
| 2024 | 3 | 21.4% |
| 2025partial year | 1 | 7.1% |
Top 8 of 8 technology areas
Overall rank by patents
#20,474
of 50,000 tracked assignees
41.7 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.